OSMOTICA PHARMACEUTICALS PLC (OSMT) Stock Earnings & Estimates
NASDAQ:OSMT - Common Stock
1.11
-0.02 (-1.77%)
1.08
-0.03 (-2.7%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 263.7M 7.33% | 240M -8.99% | 177.9M -25.87% | 18.983M -89.33% | 56.684M 198.61% | 132.89M 134.44% | 325.712M 145.10% | 814.28M 150.00% | |
| EBITDA YoY % growth | 87.27M 29.38% | 60.02M -31.22% | 22.83M -61.96% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 5.7M -72.86% | 3M -47.37% | 1.8M -40.00% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | 2.16% | 1.25% | 1.01% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -2.73 -460.52% | -1.29 52.75% | -1.05 18.29% | -0.72 31.94% | -0.23 67.30% | -0.34 -46.68% | -0.51 -49.62% |
| Q4 / 21 | Q4 / 22 | |
|---|---|---|
| EPS Q2Q % growth | -0.30 65.81% | -0.05 82.48% |
| Revenue Q2Q % growth | 3.847M -88.86% | 255.319M 6,537.26% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | -0.28 -100.00% | -0.32 | 0.04 | 12.85% |
| Q2 2021 Q2Q % growth | -0.28 -27.27% | -0.14 | -0.14 | -96.08% |
| Q1 2021 Q2Q % growth | -0.15 -200.00% | -0.24 | 0.09 | 37.42% |
| Q4 2020 Q2Q % growth | -0.88 -72.55% | -0.24 | -0.64 | -264.54% |
| Q3 2020 Q2Q % growth | -0.14 93.49% | -0.20 | 0.06 | 31.37% |
| Q2 2020 Q2Q % growth | -0.22 -1,200.00% | -0.13 | -0.09 | -72.55% |
| Q1 2020 Q2Q % growth | -0.05 44.44% | -0.15 | 0.10 | 65.80% |
| Q4 2019 Q2Q % growth | -0.51 | -0.07 | -0.44 | -681.25% |
| Q3 2019 Q2Q % growth | -2.15 | -0.21 | -1.94 | -940.91% |
| Q2 2019 Q2Q % growth | 0.02 | -0.15 | 0.17 | 113.52% |
| Q1 2019 Q2Q % growth | -0.09 | -0.06 | -0.03 | -60.43% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 2.196M -96.16% | 2.405M | -208.823K | -8.68% |
| Q2 2021 Q2Q % growth | 12.445M -66.84% | 35.241M | -22.796M | -64.69% |
| Q1 2021 Q2Q % growth | 23.88M -50.91% | 31.263M | -7.383M | -23.62% |
| Q4 2020 Q2Q % growth | 34.53M -42.36% | 36.448M | -1.918M | -5.26% |
| Q3 2020 Q2Q % growth | 57.17M -12.66% | 37.783M | 19.387M | 51.31% |
| Q2 2020 Q2Q % growth | 37.53M -34.76% | 41.65M | -4.12M | -9.89% |
| Q1 2020 Q2Q % growth | 48.65M -14.84% | 46.381M | 2.269M | 4.89% |
| Q4 2019 Q2Q % growth | 59.91M | 54.297M | 5.613M | 10.34% |
| Q3 2019 Q2Q % growth | 65.46M | 53.252M | 12.208M | 22.93% |
| Q2 2019 Q2Q % growth | 57.53M | 59.233M | -1.703M | -2.87% |
| Q1 2019 Q2Q % growth | 57.13M | 62.9M | -5.77M | -9.17% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |